TrialThe Lancet. Oncology2020

Cabozantinib in patients with platinum-refractory metastatic urothelial carcinoma: an open-label, single-centre, phase 2 trial.

Andrea B Apolo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.